Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Polverelli · SciRah

Researcher profile · Semantic Scholar

N. Polverelli

Share profile

N. Polverelli — researcher profile on SciRah

h-index: 33
Works: 200
Citations: 3,867

Most-cited papers

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
R. Zeiser, N. Polverelli, R. Ram, S. Hashmi +12 more
2021New England Journal of Medicine371 citations Open access
Semantic Scholar
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis
M. Maffioli, B. Mora, S. Ball, A. Iurlo +23 more
2022Blood Advances121 citations Open access
Semantic Scholar
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group.
N. Kroger, A. Bacigalupo, T. Barbui, M. Ditschkowski +23 more
2023The Lancet Haematology91 citations
Semantic Scholar
Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)
N. Polverelli, K. Mauff, N. Kroger, M. Robin +25 more
2020American journal of hematology/oncology76 citations Open access
Semantic Scholar
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis
F. Palandri, G. Palumbo, E. Elli, N. Polverelli +32 more
2021Blood Cancer Journal71 citations Open access
Semantic Scholar
Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party
D. Mclornan, J. Hernández-Boluda, T. Czerw, N. Cross +9 more
2021Leukemia57 citations
Semantic Scholar
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome
F. Palandri, M. Breccia, C. Mazzoni, G. Auteri +36 more
2023Cancer46 citations Open access
Semantic Scholar
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT.
N. Polverelli, J. Hernández-Boluda, T. Czerw, T. Barbui +25 more
2022The Lancet Haematology36 citations Open access
Semantic Scholar
Second primary malignancy in myelofibrosis patients treated with ruxolitinib
N. Polverelli, E. Elli, E. Abruzzese, G. Palumbo +37 more
2020British Journal of Haematology35 citations
Semantic Scholar
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French–Italian 10-year experience on 228 patients
N. Polverelli, P. Tura, G. Battipaglia, M. Malagola +9 more
2020Bone Marrow Transplantation33 citations
Semantic Scholar
Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients with Steroid-Refractory/Steroid-Dependent Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study
R. Zeiser, N. Polverelli, R. Ram, S. Hashmi +9 more
202028 citations Open access
Semantic Scholar
GITMO REGISTRY STUDY ON ALLOGENEIC TRANSPLANTATION IN PATIENTS AGED OVER 60 FROM 2000 TO 2017. IMPROVEMENTS AND CRITICISMS.
M. Malagola, N. Polverelli, Vicky Rubini, M. Martino +33 more
2021Transplantation and Cellular Therapy27 citations Open access
Semantic Scholar
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Guillermo Ortí, L. Gras, N. Zinger, M. Finazzi +22 more
2023American journal of hematology/oncology25 citations Open access
Semantic Scholar
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome
F. Palandri, M. Tiribelli, M. Breccia, D. Bartoletti +31 more
2021Cancer25 citations Open access
Semantic Scholar
A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation
E. Morello, M. G. Guarinoni, F. Arena, M. Andreoli +5 more
2021Frontiers in Immunology25 citations Open access
Semantic Scholar
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)
D. Russo, N. Polverelli, M. Malagola, M. Farina +55 more
2021Bone Marrow Transplantation24 citations Open access
Semantic Scholar
Seasonal human coronaviruses respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation.
J. Piñana, A. Xhaard, G. Tridello, J. Passweg +31 more
2020Journal of Infectious Diseases24 citations Open access
Semantic Scholar
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee
D. Mclornan, T. Czerw, G. Damaj, M. Ethell +17 more
2024Leukemia22 citations
Semantic Scholar
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients?
C. Zanaglio, S. Bernardi, L. Gandolfi, M. Farina +7 more
2020Case Reports in Oncology22 citations Open access
Semantic Scholar
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial.
Domenico Russo, N. Polverelli, S. Bernardi, S. Santarone +31 more
2024The Lancet Haematology21 citations
Semantic Scholar
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy
F. Palandri, G. Palumbo, G. Benevolo, A. Iurlo +33 more
2023Cancer20 citations Open access
Semantic Scholar
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients
G. Benevolo, E. Elli, D. Bartoletti, R. Latagliata +24 more
2021Hematological Oncology20 citations
Semantic Scholar
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study
M. Malagola, A. Iurlo, E. Abruzzese, M. Bonifacio +28 more
2021Cancer Medicine20 citations Open access
Semantic Scholar
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real‐world data
F. Palandri, M. Breccia, M. Tiribelli, M. Bonifacio +29 more
2020Hematological Oncology20 citations Open access
Semantic Scholar
dsDNA from extracellular vesicles (EVs) in adult AML
S. Bernardi, C. Zanaglio, M. Farina, N. Polverelli +2 more
2020Annals of Hematology18 citations Open access
Semantic Scholar
Advances in CMV Management: A Single Center Real-Life Experience
M. Malagola, C. Pollara, N. Polverelli, T. Zollner +14 more
2020Frontiers in Cell and Developmental Biology17 citations Open access
Semantic Scholar
CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted Patients
M. Malagola, R. Greco, S. Santarone, A. Natale +22 more
2019Mediterranean Journal of Hematology and Infectious Diseases16 citations Open access
Semantic Scholar
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial
M. Mazzucconi, Francesco Rodeghiero, Giuseppe Avvisati, V. De Stefano +36 more
2024Blood Advances15 citations Open access
Semantic Scholar
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study
F. Palandri, E. Rossi, G. Auteri, M. Breccia +33 more
2023Cancers15 citations Open access
Semantic Scholar
Twenty years of evolution of CML therapy: how the treatment goal is moving from disease to patient
Domenico Russo, M. Malagola, N. Polverelli, M. Farina +2 more
2023Therapeutic Advances in Hematology15 citations Open access
Semantic Scholar
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients
M. Farina, Marco Chiarini, C. Almici, Eugenia Accorsi Buttini +20 more
2022Cancers15 citations Open access
Semantic Scholar
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection
S. Bernardi, M. Farina, K. Bosio, Anna Di Lucanardo +10 more
2022Cancers15 citations Open access
Semantic Scholar
Exosomes in Chronic Myeloid Leukemia: Are We Reading a New Reliable Message?
S. Bernardi, M. Malagola, N. Polverelli, D. Russo
2020Acta Haematologica15 citations Open access
Semantic Scholar
Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives
M. Breccia, F. Palandri, N. Polverelli, Morena Caira +3 more
2024Frontiers in Oncology14 citations Open access
Semantic Scholar
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review
Eugenia Accorsi Buttini, M. Farina, L. Lorenzi, N. Polverelli +13 more
2023Frontiers in Oncology14 citations Open access
Semantic Scholar
TIM-3 Inhibitor Sabatolimab for Patients with Acute Myeloid Leukemia (AML) with Measurable Residual Disease (MRD) Detected after Allogeneic Stem Cell Transplantation (AlloSCT): Preliminary Findings from the Phase Ib/II Stimulus-AML2 Study
R. Zeiser, Raynier Devillier, M. Mico', David Valcárcel +8 more
2023Blood14 citations Open access
Semantic Scholar
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)
M. Malagola, A. Turra, L. Signorini, S. Corbellini +15 more
2022Frontiers in Oncology14 citations Open access
Semantic Scholar
Nutritional intervention with TGF-BETA enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improves overall survival in patients undergoing allogeneic hematopoietic stem transplantation.
E. Morello, G. Brambilla, S. Bernardi, Vincenzo Villanacci +12 more
2023Transplant Immunology13 citations Open access
Semantic Scholar
How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation
N. Polverelli, M. Farina, M. D'Adda, E. Damiani +5 more
2022Cells13 citations Open access
Semantic Scholar
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic‐phase myelofibrosis
F. Palandri, D. Bartoletti, A. Iurlo, M. Bonifacio +31 more
2021Cancer13 citations Open access
Semantic Scholar
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
M. Malagola, V. Radici, M. Farina, S. Pellizzeri +10 more
2023Bone Marrow Transplantation12 citations Open access
Semantic Scholar
Incidence of blast phase in myelofibrosis according to anemia severity
B. Mora, M. Maffioli, E. Rumi, P. Guglielmelli +21 more
2023eJHaem11 citations Open access
Semantic Scholar
Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis
M. Farina, S. Bernardi, N. Polverelli, M. D'Adda +7 more
2021Cells11 citations Open access
Semantic Scholar
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
M. Gemelli, E. Elli, C. Elena, A. Iurlo +15 more
2020Blood Research11 citations Open access
Semantic Scholar
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
M. Malagola, N. Polverelli, M. Martino, F. Patriarca +33 more
2023Transplantation Direct10 citations Open access
Semantic Scholar
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis
F. Palandri, G. A. Palumbo, M. Bonifacio, E. Elli +33 more
2023Cancers10 citations Open access
Semantic Scholar
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study
E. Elli, A. Di Veroli, D. Bartoletti, A. Iurlo +26 more
2022British Journal of Haematology10 citations Open access
Semantic Scholar
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT
N. Polverelli, E. Bonneville, L. D. de Wreede, L. Koster +25 more
2024American journal of hematology/oncology9 citations Open access
Semantic Scholar
Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients
Eugenia Accorsi Buttini, Cristina Doran, M. Malagola, V. Radici +10 more
2024Cancers9 citations Open access
Semantic Scholar
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
M. Robin, S. Iacobelli, L. Koster, J. Passweg +21 more
2024Bone Marrow Transplantation8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Malagola×22
Invite
M. Malagola — researcher profile on SciRah
D. Russo×16
Invite
D. Russo — researcher profile on SciRah
M. Farina×16
Invite
M. Farina — researcher profile on SciRah
F. Palandri×15
Invite
F. Palandri — researcher profile on SciRah

×15

Invite

S. Bernardi — researcher profile on SciRah

Invite

E. Elli — researcher profile on SciRah

Invite

A. Iurlo — researcher profile on SciRah

M. Tiribelli×12

Invite

M. Tiribelli — researcher profile on SciRah

M. Crugnola×12

Invite

M. Crugnola — researcher profile on SciRah

Invite

M. Breccia — researcher profile on SciRah

M. Bonifacio×12

Invite

M. Bonifacio — researcher profile on SciRah

G. Benevolo×11

Invite

G. Benevolo — researcher profile on SciRah